Autor: Firma Immunic

Immunic, Inc. Announces Changes to Executive Team

20. April 202013. Dezember 2023 Firma ImmunicFirmeninternclinical, expenses, financial, fiscal, immunic, immunic's, imu, market, mba, report, revenue, securities, statements, treatment, with

Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company focused on developing best-in-class, oral therapies for the treatment of chronic inflammatory and autoimmune diseases, today announced a series of changes to its Executive Team, including the departure of Chief Financial Officer, Sanjay Mehr

Immunic, Inc. Reports Year End 2019 Financial Results and Highlights Recent Achievements

17. März 202013. Dezember 2023 Firma ImmunicForschung und Entwicklung4sc, caldose, dosing, fiscal, immunic, immunic's, imu, market, patients, psc, psoriasis, revenue, statements, ulcerative, with

Immunic, Inc. (Nasdaq: IMUX), a clinical-stage biopharmaceutical company focused on developing best-in-class, oral therapies for the treatment of chronic inflammatory and autoimmune diseases, today announced financial results for the year ended December 31, 2019 and highlighted recent achievements. "In addition to Mehr